Human Molecular Genetics, Vol 7, 991-997, Copyright © 1998 by Oxford University Press
D Tait, M Riccio, A Sittler, E Scherzinger, S Santi, A Ognibene, NM Maraldi, H Lehrach and EE Wanker
It has been reported that the ataxin-3 protein containing a polyglutamine
sequence in the pathological range (61-84Q) is localized within the nucleus
of neuronal cells, whereas ataxin-3 with a normal repeat length (12-37Q) is
predominantly a cytoplasmic protein. In this study, the subcellular
localization of the full-length ataxin-3 protein with a glutamine sequence
in the normal range (Q3KQ22) was analysed in two mammalian cell lines.
Using two affinity-purified polyclonal antibodies raised against the N- or
C-terminal portion of ataxin-3, the protein was detected predominantly, but
not exclusively, in the nucleus of COS-7 as well as neuroblastoma cells by
immunofluorescence and confocal laser scanning microscopy (CLSM). The
distribution of the protein in these cellular compartments was confirmed by
biochemical subcellular fractionations. Furthermore, CLSM revealed that the
ataxin- 3 protein present in the nucleus of neuroblastoma cells is
associated with the inner nuclear matrix. Our results taken together with
the finding of a nuclear localization signal in ataxin-3 indicate that the
ataxin-3 protein per se translocates to the nucleus and that an expanded
glutamine repeat is not essential for this transport.
ARTICLES
Ataxin-3 is transported into the nucleus and associates with the nuclear matrix
Max-Planck Institut fur Molekulare Genetik, Ihnestrasse 73, D-14195 Berlin (Dahlem), Germany.
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
S. Alves, E. Regulier, I. Nascimento-Ferreira, R. Hassig, N. Dufour, A. Koeppen, A. L. Carvalho, S. Simoes, M. C. P. de Lima, E. Brouillet, et al. Striatal and nigral pathology in a lentiviral rat model of Machado-Joseph disease Hum. Mol. Genet., July 15, 2008; 17(14): 2071 - 2083. [Abstract] [Full Text] [PDF] |
||||
![]() |
U. Bichelmeier, T. Schmidt, J. Hubener, J. Boy, L. Ruttiger, K. Habig, S. Poths, M. Bonin, M. Knipper, W. J. Schmidt, et al. Nuclear Localization of Ataxin-3 Is Required for the Manifestation of Symptoms in SCA3: In Vivo Evidence J. Neurosci., July 11, 2007; 27(28): 7418 - 7428. [Abstract] [Full Text] [PDF] |
||||
![]() |
A.-J. Rodrigues, G. Coppola, C. Santos, M. d. C. Costa, M. Ailion, J. Sequeiros, D. H. Geschwind, and P. Maciel Functional genomics and biochemical characterization of the C. elegans orthologue of the Machado-Joseph disease protein ataxin-3 FASEB J, April 1, 2007; 21(4): 1126 - 1136. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. U. Hubbers, C. S. Clemen, K. Kesper, A. Boddrich, A. Hofmann, O. Kamarainen, K. Tolksdorf, M. Stumpf, J. Reichelt, U. Roth, et al. Pathological consequences of VCP mutations on human striated muscle Brain, February 1, 2007; 130(2): 381 - 393. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. E. Riley and H. T Orr Polyglutamine neurodegenerative diseases and regulation of transcription: assembling the puzzle. Genes & Dev., August 15, 2006; 20(16): 2183 - 2192. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Goti, S. M. Katzen, J. Mez, N. Kurtis, J. Kiluk, L. Ben-Haiem, N. A. Jenkins, N. G. Copeland, A. Kakizuka, A. H. Sharp, et al. A Mutant Ataxin-3 Putative-Cleavage Fragment in Brains of Machado-Joseph Disease Patients and Transgenic Mice Is Cytotoxic above a Critical Concentration J. Neurosci., November 10, 2004; 24(45): 10266 - 10279. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. M. Everett and N. W. Wood Trinucleotide repeats and neurodegenerative disease Brain, November 1, 2004; 127(11): 2385 - 2405. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Chai, S. S. Berke, R. E. Cohen, and H. L. Paulson Poly-ubiquitin Binding by the Polyglutamine Disease Protein Ataxin-3 Links Its Normal Function to Protein Surveillance Pathways J. Biol. Chem., January 30, 2004; 279(5): 3605 - 3611. [Abstract] [Full Text] [PDF] |
||||
![]() |
U. Rub, R. A. I. de Vos, C. Schultz, E. R. Brunt, H. Paulson, and H. Braak Spinocerebellar ataxia type 3 (Machado-Joseph disease): severe destruction of the lateral reticular nucleus Brain, September 1, 2002; 125(9): 2115 - 2124. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Takahashi, H. Fujigasaki, C. Zander, K. H. El Hachimi, G. Stevanin, A. Durr, A.-S. Lebre, G. Yvert, Y. Trottier, H. d. The, et al. Two populations of neuronal intranuclear inclusions in SCA7 differ in size and promyelocytic leukaemia protein content Brain, July 1, 2002; 125(7): 1534 - 1543. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. O. Evert, I. R. Vogt, C. Kindermann, L. Ozimek, R. A. I. de Vos, E. R. P. Brunt, I. Schmitt, T. Klockgether, and U. Wullner Inflammatory Genes Are Upregulated in Expanded Ataxin-3-Expressing Cell Lines and Spinocerebellar Ataxia Type 3 Brains J. Neurosci., August 1, 2001; 21(15): 5389 - 5396. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. D. Wood, F. C. Nucifora Jr., K. Duan, C. Zhang, J. Wang, Y. Kim, G. Schilling, N. Sacchi, J. M. Liu, and C. A. Ross Atrophin-1, the Dentato-Rubral and Pallido-Luysian Atrophy Gene Product, Interacts with Eto/Mtg8 in the Nuclear Matrix and Represses Transcription J. Cell Biol., September 4, 2000; 150(5): 939 - 948. [Abstract] [Full Text] [PDF] |
||||
![]() |
G.-h. Wang, N. Sawai, S. Kotliarova, I. Kanazawa, and N. Nukina Ataxin-3, the MJD1 gene product, interacts with the two human homologs of yeast DNA repair protein RAD23, HHR23A and HHR23B Hum. Mol. Genet., July 22, 2000; 9(12): 1795 - 1803. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. I. Diamond, M. R. Robinson, and K. R. Yamamoto Regulation of expanded polyglutamine protein aggregation and nuclear localization by the glucocorticoid receptor PNAS, January 18, 2000; 97(2): 657 - 661. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. M. Boutell, P. Thomas, J. W. Neal, V. J. Weston, J. Duce, P. S. Harper, and A. L. Jones Aberrant interactions of transcriptional repressor proteins with the Huntington's disease gene product, huntingtin Hum. Mol. Genet., September 1, 1999; 8(9): 1647 - 1655. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. O. Evert, U. Wullner, J. B. Schulz, M. Weller, P. Groscurth, Y. Trottier, A. Brice, and T. Klockgether High level expression of expanded full-length ataxin-3 in vitro causes cell death and formation of intranuclear inclusions in neuronal cells Hum. Mol. Genet., July 1, 1999; 8(7): 1169 - 1176. [Abstract] [Full Text] [PDF] |
||||
![]() |
S.-H. Li, A. L. Cheng, H. Li, and X.-J. Li Cellular Defects and Altered Gene Expression in PC12 Cells Stably Expressing Mutant Huntingtin J. Neurosci., July 1, 1999; 19(13): 5159 - 5172. [Abstract] [Full Text] [PDF] |
||||
![]() |
A Bavelloni, S Santi, A Sirri, M Riccio, I Faenza, N Zini, S Cecchi, A Ferri, P Auron, N. Maraldi, et al. Phosphatidylinositol 3-kinase translocation to the nucleus is induced by interleukin 1 and prevented by mutation of interleukin 1 receptor in human osteosarcoma Saos-2 cells J. Cell Sci., January 3, 1999; 112(5): 631 - 640. [Abstract] [PDF] |
||||
![]() |
M. K. Perez, H. L. Paulson, S. J. Pendse, S. J. Saionz, N. M. Bonini, and R. N. Pittman Recruitment and the Role of Nuclear Localization in Polyglutamine-mediated Aggregation J. Cell Biol., December 14, 1998; 143(6): 1457 - 1470. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Chai, L. Wu, J. D. Griffin, and H. L. Paulson The Role of Protein Composition in Specifying Nuclear Inclusion Formation in Polyglutamine Disease J. Biol. Chem., November 21, 2001; 276(48): 44889 - 44897. [Abstract] [Full Text] [PDF] |
||||








